norethindrone has been researched along with Venous Thrombosis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Abdulhai, SA; El-Ali, MW; El-Dahshan, Mel-S | 1 |
| Eiken, P; Jensen, JE; Køber, L; Mosekilde, L; Rejnmark, L; Schierbeck, LL; Stilgren, L; Tofteng, CL | 1 |
| Borowiecka, M; Nowak, P; Połać, I; Wilamowska, A | 1 |
| Cannegieter, SC; Helmerhorst, FM; Lijfering, WM; Roach, RE; Rosendaal, FR; van Hylckama Vlieg, A | 1 |
| Andersen, TO; Eilertsen, AL; Høibraaten, E; Os, I; Sandset, PM; Sandvik, L | 1 |
| Braat, DD; Hemelaar, M; Kenemans, P; Rosing, J; Thomassen, MC; van der Mooren, MJ | 1 |
| Schaudig, K; Thomssen, C | 1 |
| Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM | 1 |
| Alexandrou, AP; Bastounis, E; Bramis, J; Christodoulakos, GE; Creatsas, GC; Dalamanga, A; Keramaris, NC; Lambrinoudaki, IV | 1 |
| Grewal, S; Iroh Tam, PY; Richardson, M | 1 |
| Andersen, TO; Høibraaten, E; Mowinckel, MC; Qvigstad, E; Sandset, PM | 1 |
| Bannemerschult, R; Düsterberg, B; Endrikat, J; Gerlinger, C; Junge, W; Noah, M; Ruebig, A; Schmidt, W | 1 |
8 trial(s) available for norethindrone and Venous Thrombosis
| Article | Year |
|---|---|
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
Topics: Breast Neoplasms; Contraceptives, Oral, Synthetic; Denmark; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Follow-Up Studies; Heart Failure; Hormone Replacement Therapy; Hospitalization; Humans; Middle Aged; Myocardial Infarction; Neoplasms; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Risk; Stroke; Time Factors; Treatment Outcome; Venous Thrombosis | 2012 |
Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration.
Topics: Administration, Oral; Blood Coagulation; Cardiovascular Diseases; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrinolysis; Humans; Menopause; Middle Aged; Norethindrone; Poland; Postmenopause; Progestins; Risk Factors; Transdermal Patch; Venous Thrombosis | 2013 |
The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
Topics: Administration, Cutaneous; Administration, Oral; Blood Coagulation; C-Reactive Protein; Drug Combinations; Estradiol; Estriol; Female; Hormone Replacement Therapy; Humans; Interleukin-6; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; P-Selectin; Risk Factors; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Venous Thrombosis | 2005 |
Less effect of intranasal than oral hormone therapy on factors associated with venous thrombosis risk in healthy postmenopausal women.
Topics: Activated Protein C Resistance; Administration, Intranasal; Administration, Oral; Adult; Aged; Antithrombins; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Hemostasis; Humans; Middle Aged; Norethindrone; Peptide Fragments; Protein S; Prothrombin; Treatment Outcome; Venous Thrombosis | 2006 |
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Protein C; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tablets; Thromboembolism; Treatment Outcome; Venous Thrombosis | 2007 |
The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Topics: Analysis of Variance; Blood Coagulation; Blood Coagulation Factors; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Thromboembolism; Venous Thrombosis | 2007 |
The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
Topics: Biomarkers; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Hemostasis; Hormone Replacement Therapy; Humans; Lipoproteins; Middle Aged; Multivariate Analysis; Norethindrone; Norethindrone Acetate; Recurrence; Thromboembolism; Thrombophilia; Venous Thrombosis | 2001 |
Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations.
Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Factor V; Female; Humans; Mutation; Norethindrone; Polymerase Chain Reaction; Prospective Studies; Protein C; Venous Thrombosis | 2001 |
4 other study(ies) available for norethindrone and Venous Thrombosis
| Article | Year |
|---|---|
Bleeding and thrombosis in a patient with primary antiphospholipid syndrome using norethisterone: a case report.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Contraceptives, Oral, Synthetic; Female; Hemorrhage; Humans; Menorrhagia; Norethindrone; Tomography, X-Ray Computed; Vena Cava, Inferior; Venous Thrombosis | 2015 |
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Topics: Administration, Cutaneous; Age Factors; Aged; Case-Control Studies; Contraceptives, Oral, Hormonal; Desogestrel; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Norethindrone; Norethindrone Acetate; Odds Ratio; Postmenopause; Progestins; Risk Assessment; Risk Factors; Sex Factors; Transdermal Patch; Venous Thrombosis | 2013 |
Hormonal therapy with patch or pill: how much does it matter?
Topics: Administration, Cutaneous; Administration, Oral; Blood Coagulation; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Fibrinolysis; Humans; Norethindrone; Norethindrone Acetate; Postmenopause; Pulmonary Embolism; Research Design; Risk Assessment; Risk Factors; Thromboembolism; Treatment Outcome; Venous Thrombosis | 2007 |
Fatal case of bilateral internal jugular vein thrombosis following IVIg infusion in an adolescent girl treated for ITP.
Topics: Adolescent; Anemia, Iron-Deficiency; Anticoagulants; Brain Edema; Combined Modality Therapy; Dexamethasone; Ethinyl Estradiol; Fatal Outcome; Female; Heparin; Humans; Immunoglobulins, Intravenous; Infusions, Intravenous; Jugular Veins; Mannitol; Metrorrhagia; Norethindrone; Obesity; Purpura, Thrombocytopenic, Idiopathic; Thrombectomy; Thrombolytic Therapy; Venous Thrombosis | 2008 |